
The recall covers products manufactured prior to October of 2021 and is only for specific lots. However, the brands that have recalled are staples in bathrooms across the country. Names like Dove, Suave, and ...
continue reading...
The recall covers products manufactured prior to October of 2021 and is only for specific lots. However, the brands that have recalled are staples in bathrooms across the country. Names like Dove, Suave, and ...
continue reading...
Amid a recall that has already drawn the ire of federal regulators over the glacial pace with which it has handled remediation of the matter, Philips is facing an additional recall of some of its respiratory devices over an unrelated fault.
According to Reuters, the latest recall action targets 1,700 Philips respiratory devices around the world, with 386 of them located in the United States. The recall was issued ...
continue reading...
The recall was issued by Edgewell Personal Care Company; the company that makes Banana Boat products. In a statement released to the FDA’s website, Edgewell noted that “while benzene is not an ingredient in any ...
continue reading...
An impurity was found in Pfizer’s heart and blood pressure medication Accupril that has led to a recall of several lots of the drug. The contaminant, known as a nitrosamine, can be carcinogenic at high levels and can increase a patient’s risk of developing cancer over time.
Patients are advised against stopping their medication at this time. Rather, those that are concerned that they may have pills from ...
continue reading...
Drug manufacturer Pfizer has moved to recall several lots of blood pressure pills over concerns that the medication may have been tainted with a carcinogenic contaminant. The affected medications include Accuretic, which is a tablet distributed by Pfizer itself, as well as a line of medications distributed by a second manufacturer known as Greenstone. The Greenstone lots include a pill that combines quinapril hydrochloride and hydrochlorothiazide ...
Citing a need for improvement in the way Philips has handled its duty to notify patients of the recall of a variety of its ventilators and breathing aids, the FDA issued an order to the corporation earlier this month mandating a more open flow of information.
In a statement on the agency’s website, the director of its Center for Devices and Radiological Health acknowledged ...
continue reading...